Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 17, 2005

View Archived Issues

Sangamo and Pfizer enter enhanced protein production research collaboration

Chugai licenses Xencor's XmAb technology for optimized antibodies

North American lung transplant program under way for ATG-Fresenius S

Altachem receives Canadian governmental support for prostate cancer therapy

Sirna and Targeted Genetics form Huntington's disease collaboration

Sepracor and Acadia announce CNS R&D collaboration

Phase II planned for PTH (1-34) after merger

Locus enters into CRADA with NCI to develop new cancer treatments

MEM-1003 enters U.S. safety and tolerability study for Alzheimer's

Xoma restructures Raptiva agreement with Genentech

Approvable letter for Biovail's orally disintegrating tramadol

Yasmin receives Canadian approval

Bristol-Myers Squibb and Medarex begin MDX-010 collaboration

AstraZeneca withdraws European MAA for Iressa in NSCLC

HSV-TK gene therapy program to enter phase III this year

Avastin receives E.U. approval

Long-term vitamin E supplementation reported to reduce mortality due to ALS

Novel CRTH2 receptor antagonists prepared and tested at Bayer

Evidence suggests that retinitis pigmentosa may be caused by mutations in the CA4 gene

New HIV integrase inhibitors developed by Tibotec-Virco

Raloxifene reported to reduce incidence of breast cancer in postmenopausal women

AstraZeneca patent claims new treatments for cancer

Novartis discloses sphingosine-1-phosphate receptor modulators

Incyte describes metalloprotease inhibitors for arthritis and other uses

KCNQ2 channel activators for epilepsy, neuropathic pain, etc.

ETC-216 is cardioprotective in a rabbit model of ischemia-reperfusion

PARP inhibitor reduces brain infarct size in rats

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 8, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...